William H. Rastetter, Director at Regulus Therapeutics Inc. (RGLS), bought 549,450 shares at $0.91 ($500K) on 2017-07-25, disclosed to the SEC on 2017-07-25.
Open-market purchase of $500k RGLS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.91 | 274,725 | $250K | 50.0% |
| 2 | $0.91 | 274,725 | $250K | 50.0% |
| Total | $0.91 avg | 549,450 | $500K | 100% |
| Filing → |
| NBIX | SELL | 2024-08-16 | $4.2M | — | Filing → |
| NBIX | SELL | 2024-01-04 | $2.9M | — | Filing → |
| NBIX | SELL | 2023-05-03 | $872K | — | Filing → |